- Call us: +91 97377 01204 | +91 95107 05371
- Email: info@surgicarepharma.com
- 24/7 hrs Open
-
-
Clobetasol Propionate, Gentamicin, Miconazole Nitrate & Clotrimazole Cream
Read moreClobetasol Propionate, Gentamicin, Miconazole Nitrate, and Clotrimazole Cream is a versatile treatment for mixed skin infections and inflammatory conditions. Its comprehensive formulation targets bacterial and fungal pathogens while reducing inflammation, providing quick and effective relief.
-
Clopidogrel Tablets IP 75mg
Read moreClopidogrel Tablets IP 75 mg are oral antiplatelet medications used to reduce the risk of blood clots in patients with a history of heart attack, stroke, or peripheral artery disease. The active ingredient, clopidogrel bisulfate, works by irreversibly blocking the P2Y12 ADP receptor on platelets, preventing them from clumping together. This helps reduce the risk of serious cardiovascular events such as heart attacks and strokes.
-
Clotrimazole Cream IP
Read moreClotrimazole Cream IP 1% is a topical antifungal medication used to treat a variety of skin infections caused by fungi and yeasts, such as ringworm, athlete’s foot, jock itch, candidiasis, and pityriasis versicolor. It works by disrupting the fungal cell membrane, leading to the death of the organism.
-
-
Cyanocobalamin, Folic Acid & Pyridoxine Capsules
Read moreCyanocobalamin, Folic Acid & Pyridoxine Capsules are nutritional supplements that combine essential B-vitamins to support blood formation, nerve health, and metabolic functions. Cyanocobalamin (Vitamin B12) helps produce red blood cells and maintain nerve function, Folic Acid (Vitamin B9) is crucial for DNA synthesis and preventing neural tube defects in pregnancy, and Pyridoxine (Vitamin B6) aids in amino acid metabolism and brain development. This combination is commonly prescribed for treating or preventing vitamin B deficiencies, anemia, and neuropathy.
-
New! -
Cyclopentolate Hydrochloride Ophthalmic Solution
Read moreCyclopentolate Hydrochloride Ophthalmic Solution is a prescription sterile ophthalmic preparation used to produce mydriasis (pupil dilation) and cycloplegia (paralysis of the ciliary muscle) for diagnostic and therapeutic purposes in ophthalmology. It is classified as a short-acting anticholinergic (muscarinic receptor antagonist) and is commonly employed during cycloplegic refraction, especially in pediatric patients, and in pre-operative eye exams.
-
Dabigatran Etexilate Mesylate Capsules 100mg
Read moreDabigatran Etexilate Mesylate 110 mg is an oral anticoagulant used to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation, and to treat or prevent deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also prescribed for venous thromboembolism (VTE) prevention after hip or knee replacement surgery.
-
Dapagliflozin & Metformin Extended Release Tablets (10/500 mg)
Read moreDapagliflozin & Metformin Extended Release Tablets are a fixed-dose combination used to manage type 2 diabetes mellitus in adults. Dapagliflozin, an SGLT2 inhibitor, lowers blood sugar by increasing glucose excretion through the urine, while Metformin, a biguanide, reduces glucose production in the liver and improves insulin sensitivity. Together, they offer effective glycemic control, support weight loss, and provide cardiovascular benefits. This extended-release formulation enhances tolerability, especially for gastrointestinal side effects linked to metformin.
-
Dapagliflozin 10mg, Sitagliptin 100mg & Metformin Hydrochloride (ER) 1000mg Tablets
Read moreDapagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride (Extended-Release) 1000 mg Tablets are an oral, fixed-dose combination used to manage type 2 diabetes mellitus in adults. This triple therapy combines three agents with complementary mechanisms. Dapagliflozin, an SGLT2 inhibitor, lowers blood glucose by promoting urinary glucose excretion. Sitagliptin, a DPP-4 inhibitor, enhances glucose-dependent insulin secretion and reduces glucagon levels. Metformin (ER), a biguanide, decreases hepatic glucose production and improves insulin sensitivity.
-
Dapagliflozin And Metformin Extended Release Tablets
Read moreDapagliflozin and Metformin Extended-Release Tablets are a fixed-dose oral combination used to manage Type 2 Diabetes Mellitus (T2DM). The tablet combines dapagliflozin, an SGLT2 inhibitor, and metformin, a biguanide antihyperglycemic agent in extended-release form. Together, they lower blood glucose by reducing glucose reabsorption in the kidneys (dapagliflozin) and decreasing hepatic glucose production while improving insulin sensitivity (metformin).